Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,814 | -9,188 | -36,147 | -26,717 | -29,115 |
| Depreciation Amortization | 669 | 331 | 1,237 | 943 | 1,384 |
| Other Working Capital | 774 | -152 | 784 | 1,116 | -114 |
| Other Operating Activity | 724 | 375 | 1,173 | 916 | 722 |
| Operating Cash Flow | $-17,647 | $-8,634 | $-32,953 | $-23,742 | $-27,123 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -787 | -419 | -3,500 | -1,846 | -1,124 |
| Investing Cash Flow | $-787 | $-419 | $-3,500 | $-1,846 | $-1,124 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 100 | 66 | N/A | 198 | N/A |
| Other Financing Activity | 14,398 | 6,947 | 52,734 | 29,914 | 30,102 |
| Financing Cash Flow | $14,498 | $7,013 | $52,734 | $30,112 | $30,102 |
| Beginning Cash Position | 63,798 | 63,798 | 47,517 | 47,517 | 45,662 |
| End Cash Position | 59,862 | 61,758 | 63,798 | 52,041 | 47,517 |
| Net Cash Flow | $-3,936 | $-2,040 | $16,281 | $4,524 | $1,855 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,647 | -8,634 | -32,953 | -23,742 | -27,123 |
| Capital Expenditure | -787 | -419 | N/A | -1,846 | N/A |
| Free Cash Flow | -18,434 | -9,053 | -32,953 | -25,588 | -27,123 |